Exosomes: cell-derived nanoplatforms for the delivery of cancer therapeutics H Kim, EH Kim, G Kwak, SG Chi, SH Kim, Y Yang International journal of molecular sciences 22 (1), 14, 2020 | 110 | 2020 |
Harnessing the natural healing power of colostrum: bovine milk‐derived extracellular vesicles from colostrum facilitating the transition from inflammation to tissue … H Kim, DE Kim, G Han, NR Lim, EH Kim, Y Jang, H Cho, H Jang, KH Kim, ... Advanced Healthcare Materials 11 (6), 2102027, 2022 | 42 | 2022 |
Potential of colostrum-derived exosomes for promoting hair regeneration through the transition from telogen to anagen phase H Kim, Y Jang, EH Kim, H Jang, H Cho, G Han, HK Song, SH Kim, Y Yang Frontiers in Cell and Developmental Biology 10, 815205, 2022 | 39 | 2022 |
Bovine colostrum derived-exosomes prevent dextran sulfate sodium-induced intestinal colitis via suppression of inflammation and oxidative stress G Han, H Cho, H Kim, Y Jang, H Jang, ES Kim, EH Kim, KY Hwang, K Kim, ... Biomaterials Science 10 (8), 2076-2087, 2022 | 38 | 2022 |
Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer H Kim, HJ Park, HW Chang, JH Back, SJ Lee, YE Park, EH Kim, Y Hong, ... Bioactive Materials 25, 527-540, 2023 | 28 | 2023 |
The potential of cell-penetrating peptides for mRNA delivery to cancer cells Y Kim, H Kim, EH Kim, H Jang, Y Jang, SG Chi, Y Yang, SH Kim Pharmaceutics 14 (6), 1271, 2022 | 28 | 2022 |
A Trojan-Horse Strategy by In Situ Piggybacking onto Endogenous Albumin for Tumor-Specific Neutralization of Oncogenic MicroRNA G Kwak, H Kim, J Park, EH Kim, H Jang, G Han, SY Wang, Y Yang, ... ACS nano 15 (7), 11369-11384, 2021 | 25 | 2021 |
Nanoparticles targeting innate immune cells in tumor microenvironment H Jang, EH Kim, SG Chi, SH Kim, Y Yang International journal of molecular sciences 22 (18), 10009, 2021 | 22 | 2021 |
mRNA: A promising platform for cancer immunotherapy B Kong, Y Kim, EH Kim, JS Suk, Y Yang Advanced Drug Delivery Reviews, 114993, 2023 | 19 | 2023 |
Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery H Jang, H Kim, EH Kim, G Han, Y Jang, Y Kim, JW Lee, SC Shin, EEK Kim, ... Biomaterials Research 27 (1), 124, 2023 | 11 | 2023 |
PDL1-binding peptide/anti-miRNA21 conjugate as a therapeutic modality for PD-L1high tumors and TAMs EH Kim, J Lee, G Kwak, H Jang, H Kim, H Cho, Y Jang, J Choi, SG Chi, ... Journal of Controlled Release 345, 62-74, 2022 | 11 | 2022 |
Design of PD‐L1‐Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy Y Kim, J Choi, EH Kim, W Park, H Jang, Y Jang, SG Chi, DH Kweon, ... Advanced Science, 2309917, 2024 | 10 | 2024 |
Design of siRNA Bioconjugates for Efficient Control of Cancer-Associated Membrane Receptors JW Lee, J Choi, EH Kim, J Choi, SH Kim, Y Yang ACS omega 8 (39), 36435-36448, 2023 | 3 | 2023 |
Targeted delivery of anti-miRNA21 sensitizes PD-L1high tumor to immunotherapy by promoting immunogenic cell death EH Kim, J Choi, H Jang, Y Kim, JW Lee, Y Ryu, J Choi, Y Choi, SG Chi, ... Theranostics 14 (10), 3777, 2024 | 1 | 2024 |
Targeting miR-21 to Overcome P-glycoprotein Drug Efflux in Doxorubicin-Resistant 4T1 Breast Cancer EH Kim, Y Ryu, J Choi, D Park, JW Lee, SG Chi, SH Kim, Y Yang Biomaterials Research 28, 0095, 2024 | | 2024 |
Dual-Action Protein-siRNA Conjugates for Targeted Disruption of CD47-Signal Regulatory Protein α Axis in Cancer Therapy JW Lee, HY Yoon, YJ Ko, EH Kim, S Song, S Hue, N Gupta, D Malin, ... ACS nano 18 (33), 22298-22315, 2024 | | 2024 |
Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugs H Jang, J Choi, D Park, G Han, EH Kim, K Kim, SH Kim, MK Shim, Y Yang Theranostics 14 (14), 5413, 2024 | | 2024 |